| Serial Number | 79365471 |
| Word Mark | S-DUAL |
| Filing Date | Tuesday, January 31, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 5, 2025 |
| Registration Number | 7876915 |
| Registration Date | Tuesday, August 5, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 17, 2025 |
| Goods and Services | Reagents for measurement of HBs antibody for medical purposes; crude medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for activating cellular function; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating ocular diseases; chemical preparations for use in DNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for medical or veterinary purposes, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; biotechnological preparations being reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical use, namely, for bispecific or multispecific antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, neurological disorder and for related diagnostic or therapeutic use, and for use in related assays; reagents for medical use; reagent paper for medical purposes; bispecific colostral antibody for medical purposes; medical diagnostic test strips for use in the field of blood analysis; trace element preparations for human use, namely, dietary and nutritional supplements; clinical medical reagents; therapeutic drugs for treating cancer and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antigens being pharmaceutical preparations for stimulating immune responses; colostral antibodies for medical purposes |
| Goods and Services | Multiple fusion proteins in raw material form for scientific or medical research use; diagnostic reagents for scientific or research use; enzymes for scientific or research purposes; bispecific antibody being monoclonal antibodies for in vitro scientific or medical research use; cell culture reagents for scientific and research use; monoclonal antibodies for in vitro scientific purposes; microorganisms for scientific or laboratory purposes, other than for medical and veterinary use; biological preparations for scientific or industrial laboratory purposes; fusion proteins in raw material form for scientific or medical research laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes; biochemical preparations for scientific purposes; double antibody reagents for scientific purposes; double antibody reagents for scientific purposes in biotechnological product development; biological preparations for use in biotechnology, other than for medical and veterinary use; biochemical catalysts; chemical reagents for use in genetic research for non-medical purposes |
| Goods and Services | Research relating to science, namely, scientific research; multiple nucleic acid scientific analysis; molecular scientific analysis; development of biotechnology; biochemical analysis; drug discovery services; new product design services; pharmaceutical research and development; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals, namely, product quality testing; fusion protein scientific analysis; computer programming services in the medical field; medical laboratories; computer project management services relating to imaging medical data; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing; providing scientific information on the testing, inspection and research of medical products; scientific laboratory services relating to the production of bispecific antibody; drug development of bispecific antibody; scientific research and development for double antibody reagent; evaluating of clinical trial progress, namely, conducting clinical trials for others; conducting clinical trials for others |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 20, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 20, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 20, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Samsung Biologics Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Samsung Biologics Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Samsung Biologics Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, March 16, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, March 20, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 24, 2023 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 30, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 1, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, November 2, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 2, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, November 2, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, November 22, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, May 16, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, May 16, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Thursday, May 16, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, May 20, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, May 20, 2024 | PETITION TO REVIVE-GRANTED |
| Monday, May 20, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Monday, May 20, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 14, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, August 14, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, August 31, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, May 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 6, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 15, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 15, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 15, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 15, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 16, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 11, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 17, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 17, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 5, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 5, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, November 5, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |